These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metabolism of Zearalenone and Its Major Modified Forms in Pigs. Binder SB; Schwartz-Zimmermann HE; Varga E; Bichl G; Michlmayr H; Adam G; Berthiller F Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208710 [TBL] [Abstract][Full Text] [Related]
3. Kinetics and metabolism of zearalenone in young female pigs. Dänicke S; Swiech E; Buraczewska L; Ueberschär KH J Anim Physiol Anim Nutr (Berl); 2005 Aug; 89(7-8):268-76. PubMed ID: 15972077 [TBL] [Abstract][Full Text] [Related]
4. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Kurebayashi H; Betsui H; Ohno Y Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
6. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
7. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs. Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829 [TBL] [Abstract][Full Text] [Related]
8. Minimal transmission of zearalenone to milk of dairy cows. Prelusky DB; Scott PM; Trenholm HL; Lawrence GA J Environ Sci Health B; 1990 Feb; 25(1):87-103. PubMed ID: 2140383 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
11. The disposition and pharmacokinetics of ketoconazole in the rat. Remmel RP; Amoh K; Abdel-Monem MM Drug Metab Dispos; 1987; 15(6):735-9. PubMed ID: 2893696 [TBL] [Abstract][Full Text] [Related]
12. Metabolism and pharmacokinetics of zearalenone following oral and intravenous administration in juvenile female pigs. Fleck SC; Churchwell MI; Doerge DR Food Chem Toxicol; 2017 Aug; 106(Pt A):193-201. PubMed ID: 28552786 [TBL] [Abstract][Full Text] [Related]
13. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
15. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
16. Absorption and enterohepatic circulation of baicalin in rats. Xing J; Chen X; Zhong D Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266 [TBL] [Abstract][Full Text] [Related]
17. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys. Colletti AE; Krieter PA Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272 [TBL] [Abstract][Full Text] [Related]
18. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. Ouellet DM; Pollack GM Drug Metab Dispos; 1995 Apr; 23(4):478-84. PubMed ID: 7600915 [TBL] [Abstract][Full Text] [Related]
19. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition. Shaffer CL; Gunduz M; Ryder TF; O'Connell TN Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512 [TBL] [Abstract][Full Text] [Related]
20. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice. Fullerton FR; Greenman DL; Young JF Drug Metab Dispos; 1987; 15(5):602-7. PubMed ID: 2891474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]